BioRestorative Therapies, Inc. (BRTX) › Shareholders' EquityBioRestorative Therapies, Inc. (BRTX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $02009: -$51.1K2010: -$744.2K2011: -$3.69M2012: -$5.14M2013: -$6.69M2014: -$6.89M2015: -$3.91M2016: -$5.00M2017: -$6.84M2018: -$8.64M2019: -$12.78M2020: -$1.33M2021: $10.78M2022: $10.29M2023: $10.00M2024: $8.53M2025: $356.7K$356.7K2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$356.7K-95.8%2024$8.53M-14.7%2023$10.00M-2.8%2022$10.29M-4.6%2021$10.78M+909.8%2020-$1.33M+89.6%2019-$12.78M-47.9%2018-$8.64M-26.4%2017-$6.84M-36.7%2016-$5.00M-27.9%2015-$3.91M+43.3%2014-$6.89M-3.0%2013-$6.69M-30.0%2012-$5.14M-39.5%2011-$3.69M-395.3%2010-$744.2K-1356.8%2009-$51.1K—2008$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share